Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 3.95%5.6B | -5.31%3.35B | -3.88%1.7B | -8.12%7.18B | -8.77%5.39B | -10.00%3.54B | -16.16%1.76B | 8.17%7.81B | 9.72%5.91B | 13.86%3.93B |
| Refunds of taxes and levies | 273.92%41.58M | 556.24%37.31M | 3,641.47%25.21M | -48.29%21.71M | -70.80%11.12M | -73.14%5.68M | -90.64%673.81K | -85.16%41.98M | -83.31%38.07M | -88.42%21.16M |
| Cash received relating to other operating activities | 170.56%422.9M | 169.16%213.49M | 73.10%71.3M | -51.12%193.52M | -30.23%156.31M | -45.35%79.32M | -60.69%41.19M | 29.14%395.9M | -23.34%224.04M | -18.19%145.14M |
| Cash inflows from operating activities | 9.18%6.07B | -0.61%3.6B | -0.77%1.79B | -10.39%7.39B | -9.94%5.56B | -11.58%3.62B | -18.51%1.81B | 5.62%8.25B | 4.49%6.17B | 7.47%4.1B |
| Goods services cash paid | -10.68%864.96M | -12.90%573.71M | -29.35%301.72M | -22.93%1.34B | -27.30%968.33M | -26.64%658.66M | -16.44%427.05M | -11.58%1.74B | -9.94%1.33B | -9.20%897.84M |
| Staff behalf paid | -3.98%828.63M | -3.74%556.08M | -8.37%276.11M | 0.17%1.08B | 2.49%863.01M | -0.05%577.66M | -5.30%301.31M | -1.45%1.07B | -2.71%842.02M | -2.53%577.94M |
| All taxes paid | -16.10%511.98M | -13.29%351.6M | -10.81%163.98M | 7.93%784.24M | 11.99%610.26M | 7.40%405.5M | 29.27%183.85M | -19.26%726.59M | -5.06%544.91M | -9.91%377.57M |
| Cash paid relating to other operating activities | -30.27%254.19M | -25.40%164.15M | -47.62%70.09M | -22.86%476.93M | -20.68%364.56M | -35.34%220.04M | -42.24%133.82M | 26.55%618.26M | 14.84%459.63M | 55.40%340.29M |
| Cash outflows from operating activities | -12.34%2.46B | -11.62%1.65B | -22.38%811.9M | -11.55%3.68B | -11.72%2.81B | -15.12%1.86B | -13.06%1.05B | -6.45%4.16B | -4.22%3.18B | -1.18%2.19B |
| Net cash flows from operating activities | 31.12%3.61B | 11.03%1.95B | 28.96%980.88M | -9.22%3.72B | -8.05%2.75B | -7.49%1.76B | -24.97%760.63M | 21.53%4.09B | 15.67%2.99B | 19.52%1.9B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -32.11%1.36B | -82.68%321.4M | -91.86%45.51M | -18.84%2.18B | -16.06%2B | -12.74%1.86B | -40.59%559.37M | 81.66%2.69B | 140.09%2.39B | 376.94%2.13B |
| Cash received from returns on investments | -12.47%465.88M | 98.83%231.11M | 1,459.42%144.3M | -16.75%630.21M | -14.25%532.27M | -58.72%116.23M | -95.19%9.25M | -22.31%756.99M | 13.17%620.71M | 126.54%281.57M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -73.35%181.6K | -22.19%50.37K | -37.67%3.43K | -93.52%864.24K | -94.53%681.48K | -99.51%64.74K | -74.11%5.5K | 24,794.88%13.34M | 23,165.20%12.46M | 40,668.67%13.13M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --1.27B | --1.27B | --1.27B | --1.39B | ---- | ---- | ---- |
| Cash received relating to other investing activities | -97.44%11.63M | -97.82%9.91M | -99.86%614.41K | 100.05%462M | 99.51%455.01M | 102.58%454.24M | 8,396.49%453.53M | 24.45%230.95M | 212.77%228.06M | 372.20%224.23M |
| Cash inflows from investing activities | -56.92%1.84B | -84.80%562.47M | -92.11%190.43M | 23.29%4.55B | 31.35%4.27B | 39.88%3.7B | 111.72%2.41B | 39.78%3.69B | 101.04%3.25B | 328.30%2.65B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 88.50%2.84B | 112.12%2.1B | 131.69%1.3B | -1.65%2.06B | 19.17%1.51B | 27.98%990.7M | 20.64%561.21M | 0.12%2.09B | -9.12%1.26B | -29.98%774.11M |
| Cash paid to acquire investments | 81.42%4.55B | 30.10%3.05B | -98.36%19.37M | -0.17%2.51B | 30.87%2.51B | 66.54%2.35B | 21.39%1.18B | 2.93%2.52B | 49.16%1.92B | 110.85%1.41B |
| Cash paid relating to other investing activities | -9.52%11.82M | --10.29M | --285.88K | 570.47%13.11M | 656.60%13.07M | ---- | ---- | 208.19%1.96M | --1.73M | --1.73M |
| Cash outflows from investing activities | 83.77%7.41B | 54.77%5.16B | -24.14%1.32B | -0.60%4.59B | 26.56%4.03B | 52.74%3.34B | 21.06%1.74B | -24.09%4.62B | -23.63%3.18B | -32.58%2.18B |
| Net cash flows from investing activities | -2,471.44%-5.57B | -1,359.85%-4.6B | -268.03%-1.13B | 96.09%-36.15M | 274.29%234.87M | -20.94%365.15M | 325.68%672.22M | 73.14%-923.61M | 102.46%62.75M | 117.62%461.87M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --8.7B | --8.7B | --4.7B | ---- | ---- | ---- | ---- | -27.85%4.2M | 17.93%4.2M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --300K | --100K | ---- | ---- | ---- | ---- | ---- | -27.85%4.2M | 17.93%4.2M | ---- |
| Cash from borrowing | -22.85%14.44B | 16.72%11.92B | 304.16%5.02B | 26.14%23.33B | 9.36%18.71B | 34.09%10.21B | -70.68%1.24B | -26.25%18.5B | -14.61%17.11B | -27.00%7.62B |
| Cash received relating to other financing activities | ---- | ---- | ---- | --19.69M | --19.67M | --19.67M | 69,541.14%19.67M | ---- | ---- | ---- |
| Cash inflows from financing activities | 23.52%23.14B | 101.57%20.62B | 670.40%9.73B | 26.22%23.35B | 9.44%18.73B | 34.34%10.23B | -70.21%1.26B | -26.34%18.5B | -14.66%17.12B | -27.11%7.62B |
| Borrowing repayment | -20.03%14.53B | 3.67%11.57B | 303.77%3.84B | 15.62%22.91B | 1.49%18.16B | 38.18%11.16B | -76.88%951M | -16.67%19.82B | -2.60%17.9B | -6.75%8.08B |
| Dividend interest payment | -36.33%1.54B | -19.70%617.82M | -6.11%355.18M | 1.04%2.74B | 4.34%2.41B | -47.27%769.41M | -14.85%378.29M | -8.43%2.72B | -8.90%2.31B | 128.90%1.46B |
| -Including:Cash payments for dividends or profit to minority shareholders | -60.88%189.63M | 12,200.02%155.63M | --81.1M | 21.96%328.34M | 596.50%484.75M | -93.92%1.27M | ---- | -20.06%269.22M | -69.83%69.6M | -64.15%20.8M |
| Cash payments relating to other financing activities | 1,902.83%4.05B | 2,166.95%4.04B | -60.18%34.02M | 33.27%502.41M | 9.89%202.11M | 112.63%178.3M | 71.80%85.44M | -46.64%377M | -26.62%183.92M | -36.46%83.85M |
| Cash outflows from financing activities | -3.22%20.11B | 34.04%16.23B | 198.93%4.23B | 14.18%26.16B | 1.89%20.78B | 25.87%12.11B | -69.29%1.41B | -16.55%22.91B | -3.64%20.39B | 2.00%9.62B |
| Net cash flows from financing activities | 248.36%3.03B | 333.78%4.39B | 3,707.69%5.5B | 36.33%-2.81B | 37.60%-2.04B | 6.33%-1.88B | 58.73%-152.35M | -88.65%-4.41B | -196.09%-3.28B | -297.33%-2.01B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 98.92%-2.12M | 98.45%-1.23M | 4,295.48%1.16M | -3,924.49%-158.61M | -4,183.66%-196.69M | -1,441.38%-79.2M | 99.48%-27.68K | -102.68%-3.94M | -95.11%4.82M | -90.64%5.9M |
| Net increase in cash and cash equivalents | 43.31%1.07B | 935.85%1.74B | 317.72%5.35B | 157.60%715.27M | 445.69%745.95M | -53.98%168.42M | 275.06%1.28B | 45.05%-1.24B | 77.88%-215.78M | 631.29%365.94M |
| Add:Begin period cash and cash equivalents | 36.58%2.67B | 36.58%2.67B | 36.58%2.67B | -38.84%1.96B | -38.84%1.96B | -38.84%1.96B | -38.84%1.96B | -41.41%3.2B | -41.41%3.2B | -41.41%3.2B |
| End period cash equivalent | 38.44%3.74B | 107.90%4.42B | 147.84%8.02B | 36.58%2.67B | -9.39%2.7B | -40.40%2.12B | -8.56%3.24B | -38.84%1.96B | -33.47%2.98B | -35.30%3.56B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.